Hepatitis C virus (HCV) infection remains a major public health issue with high prevalence in
Taiwan. Recently, the advent of direct-acting antiviral (DAA) agents, with higher efficacy …

Elimination of hepatitis C virus (HCV) without the need for medical intervention, known as
spontaneous clearance (SC), occurs at a significantly lower rate than in the case of hepatitis …

Background Chronic kidney disease (CKD) and hepatitis C virus (HCV) infection are closely
linked and both increase patient mortality. The association of HCV and risk of developing …

Hepatitis C virus (HCV) infection is a silent killer that leads to rapid progression of liver
cirrhosis and hepatocellular carcinoma (HCC). High prevalence of HCV infection has been …

Huge Gap Between Clinical Efficacy and Community Effectivene... : Medicine Huge Gap
Between Clinical Efficacy and Community Effectiveness in the Treatment of Chronic Hepatitis C …

New advances in the treatment of hepatitis C provide high levels of sustained viral response
but their expense limits availability in publicly funded health systems. The aim of this review …

Abstract The World Health Organization has set tremendous goals to eliminate viral hepatitis
by 2030. However, most countries are currently off the track for achieving these goals …

Background/Aims Obstacles exist in facilitating hepatitis C virus (HCV) care cascade. To
increase timely and accurate diagnosis, disease awareness and accessibility, in-hospital …

Abstract Background and Aim Hepatitis B virus (HBV) may reactivate when treating chronic
hepatitis C (CHC) with direct acting antivirals (DAA). We aim to investigate the risk of HBV …

The aim of this study is to explore the prevalence of hepatitis C virus (HCV) infection among
injection drug users (IDUs) with and without human immunodeficiency virus (HIV) infection …